Medical University of Graz | Austria
Dr. Benno Kohlmaier is a clinical researcher affiliated with the Medical University of Graz, Austria, with a strong focus on pediatric infectious diseases, emergency medicine, and inflammatory conditions. His research profile demonstrates consistent contributions to high-impact, peer-reviewed international journals, particularly in European multicenter collaborative studies. With 48 publications and more than 793 citations, he has established a solid academic footprint in pediatric clinical research. His work spans critical areas such as febrile illnesses in children, tick-borne encephalitis, bacterial infections, and diagnostic tool validation in emergency care settings. He is actively involved in translational research that bridges laboratory findings with real-world clinical applications. His contributions to large-scale studies such as PECARN validation and European infection surveillance highlight his commitment to improving pediatric diagnostic accuracy and patient outcomes. Overall, his research output reflects strong scientific rigor, international collaboration, and clinically relevant findings that contribute significantly to pediatric healthcare advancement across Europe and globally.
Professional Profile
Education
Dr. Benno Kohlmaier has pursued advanced medical education and clinical training in Austria, specializing in pediatrics and related subspecialties. He is associated with the Medical University of Graz, one of the leading academic medical institutions in Europe, known for its strong research and clinical training environment. His academic pathway includes extensive medical training in pediatric medicine, infectious diseases, and emergency care, which forms the foundation of his research expertise. Through structured postgraduate clinical training, he has developed advanced competencies in diagnosing and managing complex pediatric conditions, particularly infectious and inflammatory diseases. His academic development is strongly aligned with evidence-based medicine and translational clinical research methodologies. This strong educational background has enabled him to actively participate in international multicenter studies and contribute meaningfully to high-impact scientific publications. His training has also supported his ability to work in interdisciplinary teams, combining clinical practice with research innovation in pediatric healthcare systems across Europe.
Professional Experience
Dr. Kohlmaier has extensive professional experience in pediatric clinical medicine and academic research. He is actively engaged in hospital-based pediatric care while simultaneously contributing to international research networks. His professional work is strongly linked with emergency pediatric medicine, infectious disease diagnostics, and clinical epidemiology. He has participated in large European multicenter studies involving hospitals and research institutions across multiple countries, reflecting strong collaborative capabilities. His involvement in projects such as EU-wide infection surveillance and diagnostic validation studies demonstrates his leadership in clinically relevant research initiatives. He has worked alongside multidisciplinary teams including pediatricians, microbiologists, epidemiologists, and public health experts. His clinical experience directly supports his research, enabling him to translate patient-level observations into scientifically validated findings. He has also contributed to outbreak investigations and hospital-based epidemiological studies, strengthening healthcare response strategies. His dual role as clinician and researcher enhances his ability to bridge gaps between scientific research and practical pediatric healthcare delivery systems.
Research Interest
Dr. Kohlmaier’s primary research interests lie in pediatric infectious diseases, emergency medicine, and inflammatory disorders. His work focuses on improving diagnostic accuracy and early detection of serious infections in children, including sepsis, meningitis, and bacterial gastrointestinal infections. He is also actively involved in research on tick-borne encephalitis, viral-bacterial co-infections, and immune response markers in pediatric patients. Another key area of interest includes validation of clinical prediction tools such as PECARN rules and biomarkers like procalcitonin for use in emergency departments. His research also extends into pediatric gastroenterology, including inflammatory bowel disease and cholestatic liver disorders. He is particularly interested in translational research that connects laboratory biomarkers with clinical outcomes. His participation in large European multicenter studies reflects a strong commitment to evidence-based pediatric care. Overall, his research aims to improve early diagnosis, optimize treatment strategies, and enhance healthcare outcomes for children across emergency and inpatient clinical settings in Europe.
Award and Honor
Dr. Kohlmaier’s research profile demonstrates strong eligibility for academic recognition due to his consistent contributions to high-impact journals and international collaborative studies. His publications in journals such as The Lancet Regional Health Europe, Archives of Disease in Childhood, BMC Pediatrics, and iScience reflect significant scientific credibility. His involvement in major European research networks, including multicenter pediatric infection studies and diagnostic validation projects, highlights his recognition within the scientific community. The high citation count of over 790 and h-index of 14 further demonstrate the impact and relevance of his work in pediatric medicine. His research contributions to clinically important topics such as sepsis identification, infectious disease surveillance, and emergency pediatric care strengthen his academic profile. While formal awards are not explicitly listed in the provided data, his inclusion in large international studies and publication in top-tier journals indicates peer recognition and professional acknowledgment. Overall, his achievements position him as a strong candidate for Best Researcher Award consideration.
Conclusion
Dr. Benno Kohlmaier is a highly competent pediatric clinical researcher with strong contributions to infectious disease research and emergency medicine. His extensive publications in reputed international journals, active involvement in European multicenter studies, and impactful clinical research make him a deserving candidate for the Best Researcher Award. His work significantly improves pediatric diagnostic and treatment strategies, and he shows strong potential for continued global research leadership and academic excellence.
Publications Top Noted
- Plasma Tissue Factor Pathway Inhibitor Levels Correlate with Disease Activity and Are Associated With Altered Thrombin Generation in Pediatric Inflammatory Bowel Disease
Journal: Pharmaceutics
Year: 2025
Focus: Pediatric inflammatory bowel disease, coagulation biomarkers, disease activity assessment.
- Bacterial Gastrointestinal Infections in Pediatric Inflammatory Bowel Disease (PIBD)—A Single-Center Experience of Epidemiology, Management, and Outcome
Journal: Diagnostics
Year: 2025
Focus: Epidemiology and clinical outcomes of gastrointestinal infections in children with PIBD.
- The Value of White Blood Cell Count in Predicting Serious Bacterial Infections in Children Presenting to the Emergency Department: A Multicentre Observational Study
Journal: Archives of Disease in Childhood
Year: 2025
Focus: Pediatric emergency medicine, diagnostic biomarkers, infection prediction.
- Extrahapetic Biliary Atresia and Normal-Range Serum Gamma-Glutamyltransferase Activity: A Case Report
Journal: JPGN Reports
Year: 2024
Focus: Rare pediatric hepatology presentation and diagnostic evaluation.
- European Study Confirms the Combination of Fever and Petechial Rash as an Important Predictor of Serious Infection in Children
Journal: Acta Paediatrica
Year: 2023
Focus: Pediatric infectious diseases and emergency diagnosis.
- A Novel Framework for Phenotyping Children With Suspected or Confirmed Infection for Future Biomarker Studies
Journal: Frontiers in Pediatrics
Year: 2021
Focus: Biomarker research, pediatric infection phenotyping, multicenter clinical framework development.
